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Mortality after surgery in Europe: a 7 day cohort study
Rupert M Pearse, Rui P Moreno, Peter Bauer, Paolo Pelosi, Philipp Metnitz, Claudia Spies, Benoit Vallet, Jean-Louis Vincent, Andreas Hoeft, 
Andrew Rhodes, for the European Surgical Outcomes Study (EuSOS) group for the Trials groups of the European Society of Intensive Care Medicine 
and the European Society of Anaesthesiology*
Summary
Background Clinical outcomes after major surgery are poorly described at the national level. Evidence of heterogeneity 
between hospitals and health-care systems suggests potential to improve care for patients but this potential remains 
unconﬁ rmed. The European Surgical Outcomes Study was an international study designed to assess outcomes after 
non-cardiac surgery in Europe.
Methods We did this 7 day cohort study between April 4 and April 11, 2011. We collected data describing consecutive 
patients aged 16 years and older undergoing inpatient non-cardiac surgery in 498 hospitals across 28 European 
nations. Patients were followed up for a maximum of 60 days. The primary endpoint was in-hospital mortality. 
Secondary outcome measures were duration of hospital stay and admission to critical care. We used χ² and Fisher’s 
exact tests to compare categorical variables and the t test or the Mann-Whitney U test to compare continuous variables. 
Signiﬁ cance was set at p<0·05. We constructed multilevel logistic regression models to adjust for the diﬀ erences in 
mortality rates between countries.
Findings We included 46 539 patients, of whom 1855 (4%) died before hospital discharge. 3599 (8%) patients were 
admitted to critical care after surgery with a median length of stay of 1·2 days (IQR 0·9–3·6). 1358 (73%) patients 
who died were not admitted to critical care at any stage after surgery. Crude mortality rates varied widely between 
countries (from 1·2% [95% CI 0·0–3·0] for Iceland to 21·5% [16·9–26·2] for Latvia). After adjustment for 
confounding variables, important diﬀ erences remained between countries when compared with the UK, the country 
with the largest dataset (OR range from 0·44 [95% CI 0·19–1·05; p=0·06] for Finland to 6·92 [2·37–20·27; p=0·0004] 
for Poland).
Interpretation The mortality rate for patients undergoing inpatient non-cardiac surgery was higher than anticipated. 
Variations in mortality between countries suggest the need for national and international strategies to improve care 
for this group of patients.
Funding European Society of Intensive Care Medicine, European Society of Anaesthesiology.
Introduction
More than 230 million major surgical procedures are 
undertaken worldwide each year.1 For most patients, risks 
of surgery are low and yet evidence increasingly suggests 
that complications after surgery are an import ant cause of 
death.2–5 About 10% of patients undergoing surgery in the 
UK are at high risk of complications, accounting for 80% 
of postoperative deaths.2–4 If this rate is applicable 
worldwide, up to 25 million patients undergo high-risk 
surgical procedures each year, of whom 3 million do not 
survive until hospital discharge. Patients who develop 
complications but survive to leave hospital often have 
reduced functional independence and long-term survival.5–8
Despite obvious diﬀ erences in procedure-related and 
patient-related mortality risks, most surgical patients use 
one care pathway, sharing standard facilities for pre-
operative assessment, anaesthesia, operating rooms, post-
anaesthetic recovery, and hospital wards. This approach is 
adequate for most patients but might not meet the needs 
of the small number of patients at high risk of 
complications and death. In the USA, evidence of 
variations in postoperative mortality within health-care 
systems suggest the potential to implement measures that 
improve patient outcomes.9 Low rates of admission to 
critical care for patients at high risk of complications 
undergoing non-cardiac surgery are of particular 
concern,2–4 and might be aﬀ ected by international diﬀ er-
ences in the provision of critical care.10,11 With high volumes 
of surgery under taken, even a low rate of avoidable harm 
will be associated with many preventable deaths.
International comparative data might provide important 
insights into delivery of health care for surgical patients. 
However, little or no data are available describing provision 
of care or outcomes for unselected surgical patients. The 
objective of the European Surgical Outcomes Study 
(EuSOS) was to describe mortality rates and patterns of 
critical care resource use for patients undergoing non-
cardiac surgery across several European nations.
Methods
Study design and participants
We did this European cohort study between 0900 h (local 
time) on April 4, 2011, and 0859 h on April 11, 2011. All 
adult patients (older than 16 years) admitted to 
participating centres for elective or non-elective inpatient 
surgery commencing during the 7 day cohort period were 
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eligible for inclusion. Patients undergoing planned day-
case surgery, cardiac surgery, neurosurgery, radiological, 
or obstetric proced ures were excluded because these 
patients receive care within separate, dedicated pathways. 
Participating hospitals (appendix pp 11–68) were a 
voluntary convenience sample, identiﬁ ed through 
membership of the European Society of Intensive Care 
Medicine and the European Society of Anaesthesiology 
and by direct approach from national study coordinators. 
Ethics requirements diﬀ ered by country. In Denmark, 
centres were exempt from ethics approval because this 
study was deemed to be a clinical audit. In all other 
nations formal ethics approval was applied for and given. 
In Finland alone we were required to obtain written 
informed consent from individual patients.
Procedures
Local investigators were supported by national coordin-
ators and via a website that provided key documentation, 
including the protocol and guidance on study procedures. 
We obtained data describing perioperative care facilities 
once for each hospital at the beginning of the study. We 
collected data describing consecutive patients with paper 
case record forms, which we made anonymous before 
entering the information onto a secure internet-based 
electronic case record form (OpenClinica, Boston, MA, 
USA). We completed an operating theatre case report 
form for each eligible patient who we then followed up 
until hospital discharge for data describing hospital stay, 
admission to critical care, and in-hospital mortality. We 
completed a critical care case record form to capture data 
describing the ﬁ rst admission to critical care for any 
individual patient at any time during the follow-up 
period. Example case record forms are available from the 
study website.
We selected patient-level variables on the basis that they 
were objective, routinely collected for clinical reasons, 
could be transcribed with a high level of accuracy, and 
would be relevant to a risk adjustment model in most 
patients. We censored critical care and hospital discharge 
data at 60 days after surgery. We assessed data for 
completeness and then checked for plausibility and 
consistency with prospectively deﬁ ned ranges.12
The primary endpoint was in-hospital mortality. 
Secondary outcome measures were duration of hospital 
stay and admission to critical care.
Statistical analysis
Our aim was to recruit as many participating hospitals 
as possible and to recruit every eligible patient in those 
hospitals. We anticipated that a minimum sample size of 
20 000 patients would enable a precise estimate of 
mortality. This sample size was also expected to provide a 
suﬃ  cient number of events (>200) for construction of a 
robust logistic regression model for mortality.
We used SPSS (version 19.0) for data analysis. 
Categorical variables are presented as number (%) and 
continuous variables as mean (SD) when normally 
distributed or median (IQR) when not. We used χ² and 
Fisher’s exact tests to compare categorical variables and 
the t test or the Mann-Whitney U test to compare 
continuous variables. Signiﬁ cance was set at p<0·05. We 
constructed several binary logistic regression models to 
identify factors independently associated with hospital 
mortality and to adjust for diﬀ erences in confounding 
factors between countries. These included a one-level 
model and a hierarchical two-level generalised linear 
mixed model, with patients being at the ﬁ rst level and 
hospital at the second. Factors were entered into the 
model based on their univariate relation to outcome 
(p<0·05). All factors were biologically plausible with a 
sound scientiﬁ c rationale and a low rate of missing data. 
The results of the model are reported as adjusted odds 
ratios (OR) with 95% CI. We assessed the models 
through sensitivity analyses with three random (disjoint) 
subsamples of countries and a fourth sample removing 
all patients from the largest country in the dataset (the 
UK). We explored all possible interacting factors and 
examined how they might have aﬀ ected the ﬁ nal results.
This study is registered with ClinicalTrials.gov, number 
NCT01203605.
Role of the funding source
The study was funded by the European Society of 
Intensive Care Medicine and the European Society of 
Anaesthesiology who appointed an independent steering 
committee (appendix p 11), who were responsible for 
study design, conduct, and data analysis. Members of the 
steering committee had full access to the study data and 
were solely responsible for interpretation of the data, 
drafting and critical revision of the report, and the 
decision to submit for publication.
For the EuSoS study protocol 
see http://eusos.esicm.org
Figure 1: Study proﬁ le
(A) All patients. (B) Patients admitted to critical care. CRF=case report form.
46 985 patients with operating room CRF
236 duplicates
46 749 with data available for inclusion
206 with inconsistent data
46 543 available for analysis
4 with missing hospital 
outcome data
46 539 included in analysis
A
3635 patients with critical care CRF
9 duplicates
3626 with data available for inclusion
23 with missing operating room data
3603 available for analysis
4 with missing hospital 
outcome data
3599 included in analysis
B
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Results
We collected data describing patients undergoing in-
patient surgery in 498 hospitals across 28 European 
nations. Median number of operating theatres in each 
hospital was 15 (IQR 10–22) and median number of 
critical care beds was 19 (9–40). Data were returned for 
46 985 cases of which 446 were removed having been 
identiﬁ ed as duplicates or having missing critical care or 
mortality data, leaving 46 539 for analysis (ﬁ gure 1). A 
median number of 83 (39–125) patients were included 
per hospital and 1045 (455–1732) per coun try. 281 (56%) 
hospitals were aﬃ  liated to a university, recruiting 
31 132 patients (68% of total, appendix p 2).
Table 1 shows baseline data for all patients. Overall 
crude mortality was 4·0% and the median duration of 
hospital stay was 3·0 days (IQR 1·0–7·0). Prevalence of 
comorbid disease, grade of surgery, crude mortality rates, 
duration of hospital stay, and number of critical care 
admissions diﬀ ered substantially between countries 
(table 2, appendix p 2). Table 2 shows unadjusted OR for 
hospital mortality by country. 3599 patients (8%) were 
admitted to critical care at some point during hospital 
stay, of whom 2555 (71%) had planned admissions 
(ﬁ gure 2). Median stay in critical care was 1·2 days 
(0·9–3·6). 1358 patients who died were not admitted to 
critical care at any stage after surgery (73% of all deaths). 
506 patients (14%) admitted to critical care died before 
hospital discharge, of whom 218 (43%) died after the ﬁ rst 
admission to critical care was complete.
We explored variables associated with hospital mortality 
in a univariate analysis, the ﬁ ndings of which were much 
the same as for a sensitivity analysis of diﬀ erent subsets 
of the database (table 1, appendix pp 3–4). We then 
constructed several binary logistic regression models to 
adjust for baseline diﬀ erences that might explain the 
unadjusted OR for individual countries (table 2). We 
developed both single-level and multilevel models 
(appendix pp 5–8) with variables that were signiﬁ cant in 
the univariate analysis. The point estimates for the OR 
did not diﬀ er greatly between the one-level and two-level 
models, but the hierarchical model consistently provided 
a more conservative estimate of country eﬀ ects across the 
sensitivity tests (appendix p 9).
We constructed a further model including all signiﬁ cant 
interacting factors (appendix p 10). Since this increased 
model complexity did not substantially change the 
country-level estimates, we report results of the more 
parsimonious two-level model without interactions 
(ﬁ gure 3). Factors that were independently associated with 
mortality and that we therefore used to adjust for baseline 
confounders were: country where surgery was done, 
urgency of surgery, grade of surgery, surgical procedure 
category, age, American Society of Anesthesi ologists 
(ASA) score, metastatic disease, and cirrhosis (appendix 
pp 7–8). We entered ASA score rather than the Lee Revised 
Cardiac Index because, although the two were highly 
correlated, less data describing ASA score were missing.
All patients 
(n=46 539)
Died in 
hospital 
(n=1864)
Survived to 
hospital 
discharge 
(n=44 657)
Odds ratio (95% CI) p value
Age (years) 56·7 (18·5) 61·0 (18·7) 56·6 (18·5) 1·01 (1·01–1·02) <0·0001
Men 22 607 968 21 629 1·15 (1·05–1·26) 0·003
Present smoker 9872 363 9503 0·90 (0·80–-1·01) 0·07
ASA score
1 11 642 362 11 280 Reference ··
2 21 582 633 20 944 0·94 (0·83–1·07) 0·36
3 11 574 539 11 025 1·51 (1·32–1·73) <0·0001
4 1559 279 1277 6·75 (5·71–7·97) <0·0001
5 90 49 41 35·61 (23·23–54·59) <0·0001
Grade of surgery
Minor 12 041 431 11 608 Reference ··
Intermediate 22 231 741 21 483 0·93 (0·82–1·05) 0·22
Major 12 170 685 11 476 1·59 (1·40–1·80) <0·0001
Urgency of surgery
Elective 35 049 1129 33 908 Reference ··
Urgent 8923 483 8436 1·71 (1·52–1·91) <0·0001
Emergency 2557 249 2303 3·20 (2·77–3·70) <0·0001
Surgical specialty
Orthopaedics 12 214 468 11 744 1·02 (0·84–1·24) 0·85
Breast 1500 43 1456 0·76 (0·53–1·07) 0·12
Gynaecology 3972 115 3857 0·76 (0·59–0·99) 0·04
Vascular 2376 140 2233 1·61 (1·26–2·05) 0·0001
Upper 
gastrointestinal
2228 155 2071 1·88 (1·48–2·39) 0·0001
Lower 
gastrointestinal
4972 284 4683 1·54 (1·25–1·91) 0·0001
Hepato-biliary 2247 113 2134 1·35 (1·04–1·74) 0·025
Plastic or 
cutaneous
2432 73 2356 0·79 (0·59–1·06) 0·12
Urology 4881 144 4737 0·78 (0·61–0·99) 0·042
Kidney 463 9 454 0·51 (0·26–1·01) 0·05
Head and neck 5640 174 5466 0·82 (0·65–1·03) 0·09
Other 3463 132 3329 Reference
Laparoscopic surgery 5510 160 5350 0·69 (0·59–0·82) <0·0001
Comorbid disorder
Cirrhosis 498 65 433 3·64 (2·79–4·76) <0·0001
Congestive heart 
failure
2154 166 1985 2·10 (1·78–2·48) <0·0001
COPD 5162 244 4912 1·21 (1·05–2·48) 0·008
Coronary artery 
disease
6274 387 5881 1·73 (1·54–1·94) <0·0001
Diabetes (taking 
insulin)
2081 135 1939 1·73 (1·44–2·07) <0·0001
Diabetes (not 
taking insulin)
3495 147 3348 1·05 (0·88–1·24) 0·61
Metastatic cancer 2173 155 2017 1·91 (1·61–2·27) <0·0001
Stroke 2006 120 1884 1·57 (1·30–1·90) <0·0001
Data are mean (SD) or n unless otherwise speciﬁ ed. Odds ratios were constructed for in-hospital mortality with 
univariate binary logistic regression analysis. ASA=American Society of Anesthesiologists. COPD=chronic obstructive 
pulmonary disease.
Table 1: Description of cohort
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With the UK study population as the reference category, 
we identiﬁ ed higher unexplained rates of mortality in 
Poland, Romania, Latvia, and Ireland (table 2, ﬁ gure 3).
Discussion
This international prospective study has provided data 
for a population of more than 46 000 unselected patients 
undergoing inpatient surgery from 28 European coun-
tries. 4% of included patients died before hospital dis-
charge, which was a higher mortality rate than 
expected.2,3,6,13–16 We identiﬁ ed substantial diﬀ erences in 
crude and risk adjusted mortality rates between 
countries. When compared with the UK, the recorded 
mortality rates for Poland, Latvia, Romania, and Ireland 
were higher even after adjustment for all identiﬁ ed 
confounding variables. This pattern could relate to 
cultural, demographic, socio economic, and political 
diﬀ erences between nations, which might aﬀ ect 
population health and health-care outcomes.
A major strength of our study was the large number of 
consecutive unselected patients enrolled in a multicentre 
and multinational setting. A vigorous approach to follow-
up for missing and incomplete data provided a high-
quality dataset for analysis. The dataset allowed us to 
explore probable prognostic factors and to adjust crude 
mortality rates to describe diﬀ erences in outcomes 
between countries. Our analysis identiﬁ ed several factors 
associated with increased mortality. These ﬁ ndings 
suggest that surgery-related and patient-related factors 
interact to increase mortality risk. Only two comorbid 
disease categories were identiﬁ ed as independent 
variables. This ﬁ nding probably arose because the ASA 
score was designed to describe the severity of coexisting 
medical disease.
Evidence suggests that critical-care-based cardio respir-
atory interventions can improve outcomes among high-
risk surgical patients.17–21 However, in our study, only 5% of 
patients underwent a planned admission to critical care 
with a median stay of about 1 day. Unplanned admissions 
to critical care were associated with higher mortality rates 
than were planned admissions. Remark ably, most patients 
who died (73%) were not admitted to critical care at any 
Number of 
patients
Median days in 
hospital (IQR)
Number admitted 
to critical care
Percentage admitted 
to critical care (95% CI)
Number died 
in hospital
Percentage died in 
hospital (95% CI)
Unadjusted OR 
(95% CI)
Adjusted OR 
(95% CI)
p value
Belgium 1486 3·0 (1·0–6·0) 136 9·2% (7·7–10·6) 47 3·2% (2·3–4·1) 0·89 (0·65–1·21) 1·65 (0·81–3·40) 0·17
Croatia 1767 4·0 (2·0–7·0) 166 9·4% (8·0–10·8) 131 7·4% (6·2–8·6) 2·17 (1·77–2·67) 1·89 (0·94–3·80) 0·07
Cyprus 45 1·0 (1·0–3·0) 0 0 1 2·2% (0·0–6·7) 0·62 (0·09–4·48) 0·82 (0·04–16·70) 0·90
Czech Republic 434 4·0 (2·0–9·0) 21 4·8% (2·8–6·9) 10 2·3% (0·9–3·7) 0·64 (0·34–1·21) 1·30 (0·23–7·46) 0·77
Denmark 1000 2·0 (1·0–5·0) 36 3·6% (2·4–4·8) 32 3·2% (2·1–4·3) 0·90 (0·62–1·29) 1·16 (0·52–2·61) 0·72
Estonia 727 3·0 (1·0–6·0) 51 7·0% (5·2–8·9) 11 1·5% (0·6–2·4) 0·42 (0·23–0·76) 0·60 (0·16–2·28) 0·45
Finland 1071 2·0 (1·0–5·0) 43 4·0% (2·8–5·6) 21 2·0% (1·1–2·8) 0·54 (0·35–0·85) 0·44 (0·19–1·05) 0·06
France 2278 3·0 (1·0–6·0) 132 5·8% (4·8–6·8) 73 3·2% (2·5–3·9) 0·90 (0·70–1·16) 1·36 (0·72–2·56) 0·34
Germany 5284 4·0 (2·0–9·0) 611 11·6% (10·7–12·4) 133 2·5% (2·1–2·9) 0·70 (0·57–0·86) 0·85 (0·50–1·43) 0·54
Greece 1803 3·0 (2·0–7·0) 63 3·5% (2·7–4·3) 65 3·6% (2·7–4·5) 1·01 (0·78–1·33) 1·20 (0·66–2·16) 0·55
Hungary 621 4·0 (2·0–7·0) 44 7·1% (5·1–9·1) 20 3·2% (1·8–4·6) 0·90 (0·57–1·43) 1·23 (0·43–3·50) 0·69
Iceland 162 2·0 (1·0–4·0) 15 9·3% (4·8–13·8) 2 1·2% (0·0–3·0) 0·34 (0·08–1·37) 0·47 (0·07–3·41) 0·46
Ireland 856 3·0 (1·0–6·0) 66 7·7% (5·9–9·5) 55 6·4% (4·8–8·1) 1·86 (1·39–2·49) 2·61 (1·30–5·27) 0·007
Italy 2673 3·0 (2·0–7·0) 200 7·5% (6·5–8·5) 141 5·3% (4·4–6·1) 1·51 (1·24–1·84) 1·70 (0·97–2·97) 0·06
Latvia 302 4·0 (2·0–8·0) 19 6·3% (3·5–9·1) 65 21·5% (16·9–26·2) 7·44 (5·55–9·97) 4·98 (1·22–20·29) 0·025
Lithuania 375 3·0 (2·0–5·0) 14 3·7% (1·8–5·7) 10 2·7% (1·0–4·3) 0·74 (0·39–1·40) 1·21 (0·21–6·95) 0·83
Netherlands 1627 3·0 (1·0–6·0) 126 7·7% (6·4–9·0) 32 2·0% (1·3–2·7) 0·55 (0·38–0·78) 0·63 (0·28–1·41) 0·26
Norway 689 3·0 (1·0–6·0) 31 4·5% (3·0–6·1) 10 1·5% (0·6–2·4) 0·40 (0·21–0·75) 0·51 (0·17–1·49) 0·22
Poland 397 5·0 (2·0–7·5) 8 2·0% (0·6–3·4) 71 17·9% (14·1–21·7) 5·91 (4·48–7·79) 6·92 (2·37–20·27) 0·0004
Portugal 1489 3·0 (1·0–7·0) 103 6·9% (5·6–8·2) 61 4·1% (3·1–5·1) 1·16 (0·88–1·53) 1·43 (0·72–2·83) 0·31
Romania 1298 5·0 (3·0–8·0) 209 16·1% (14·1–18·1) 88 6·8% (5·4–8·2) 1·97 (1·55–2·51) 3·19 (1·61–6·29) 0·001
Serbia 85 5·0 (3·0–7·0) 1 1·2% (0·0–3·5) 2 2·4% (0·0–5·6) 0·65 (0·16–2·67) 1·06 (0·11–10·04) 0·96
Slovakia 1156 3·0 (2·0–7·0) 22 1·9% (1·1–2·7) 129 11·2% (9·3–13·0) 3·41 (2·76–4·20) 2·15 (0·91–5·07) 0·08
Slovenia 518 3·0 (1·0–7·0) 13 2·5% (1·2–3·9) 15 2·9% (1·5–4·3) 0·81 (0·48–1·37) 1·12 (0·30–4·22) 0·86
Spain 5433 3·0 (1·0–7·0) 677 12·5% (11·6–13·3) 208 3·8% (3·3–4·3) 1·08 (0·91–1·28) 1·39 (0·89–2·18) 0·15
Sweden 1314 2·0 (1·0–6·0) 42 3·2% (2·2–4·2) 24 1·8% (1·1–2·6) 0·50 (0·33–0·77) 0·58 (0·23–1·49) 0·26
Switzerland 1019 4·0 (2·0–8·0) 79 7·8% (6·1–9·4) 20 2·0% (1·1–2·8) 0·54 (0·35–0·86) 0·86 (0·25–2·97) 0·81
UK 10 630 2·0 (1·0–6·0) 671 6·3% (5·9–6·8) 378 3·6% (3·2–3·9) 1·00 ·· ··
Odds ratios (OR) referenced against the UK and adjusted for age, American Society of Anesthesiologists’ score, urgency of surgery, grade of surgery (minor, intermediate, major), surgical specialty, and the 
presence of either metastatic disease or cirrhosis in a two-level binary logistic regression model (with patient at the ﬁ rst level and hospital at the second). 
Table 2: Relation between country and in-hospital mortality
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stage after surgery. Of patients who died after admission 
to critical care, 43% did so after the initial episode was 
complete and the patient had been discharged to a 
standard ward. These ﬁ ndings suggest a systematic failure 
in the process of allocation of critical care resources. This 
notion is consistent with previous reports of a failure to 
rescue deteriorating surgical patients with a detrimental 
eﬀ ect on patient outcomes22 and the high incidence of 
myocardial injury in the days after surgery.23 For some 
patients with a poor prognosis, postoperative admission to 
critical care might have been deemed inappropriate—eg, 
after palliative surgery for disseminated malignancy. 
However, our data suggest these cases are few in number 
(<5% of patients had malignancy, table 1). Meanwhile 
other investigators have challenged the suggestion that 
patients should be oﬀ ered surgery when the standard of 
postoperative care is unlikely to be adequate for their 
needs.2 The low rate of admission to critical care prevents 
any detailed comparison of this resource between nations. 
Further research is needed to better understand whether 
early admission to critical care can improve survival after 
major surgery.
Despite the large sample size, our study might not be 
truly representative of current practice across Europe 
because only a small proportion of European hospitals 
took part. Although in some countries the patient sample 
was large enough to show national practice, the high 
proportion of patients enrolled in university hospitals in 
other countries suggests a degree of selection bias. In 
particular, our data might not show the true surgical 
Figure 2: Planned and unplanned admission to a critical-care unit according to urgency of surgery
Data are n (%) or median (IQR). We collected data describing the ﬁ rst critical care admission for any individual patient. The data presented do not describe readmission to critical care. Because of 
incomplete data for admission planning, 19 admissions to critical care are not presented in this ﬁ gure. EuSOS=European Surgical Outcomes Study. Elective=not immediately life saving; planned within 
months or weeks. Urgent=planned surgery within hours or days of the decision to operate. Emergency=as soon as possible; no delay to plan care; ideally within 24 h.
EuSOS cohort
46 539 (100%); 1864 deaths (4%)
Elective surgery
35 040 (75%); 1132 deaths (3%)
Urgent surgery
8919 (19%); 483 deaths (5%)
Emergency surgery
2557 (5%); 249 deaths (10%)
Planned 
admission to 
critical care
1864 (5%); 
32 (2%) deaths
Stay in critical 
care 1 day (1–2)
Hospital stay 
9 days (6–15)
Discharged to 
ward alive
1832 (98%); 
88 (5%) deaths 
after discharge 
from critical care
Unplanned 
critical care 
admission
278 (1%); 
22 deaths (8%)
Stay in critical 
care 2 days (1–3)
Hospital stay 
10 days (6–19)
Discharged to 
ward alive
256 (92%); 
16 (6%) deaths
after discharge 
from critical care
No admission to 
critical care
32 895 (94%); 
973 deaths (3·0%)
Hospital stay 
3 days (1–5)
Planned
admission to
critical care
490 (5%); 
54 deaths (11%)
Stay in critical 
care 2 days (1–7)
Hospital stay 
14 days (8–28)
Discharged to
ward alive
436 (89%); 
30 (7%) deaths 
after discharge 
from critical care
Unplanned
admission to
critical care
391 (4%); 
63 deaths (16%)
Stay in critical 
care 3 days (1–6)
Hospital stay 
14 days (8–26)
Discharged to
ward alive
328 (84%); 
33 (10%) deaths
after discharge 
from critical care
No admission to
critical care
8033 (90%); 
301 deaths (4%)
Hospital stay 
4 days (2–8)
Planned
admisison to
critical care
201 (8%); 
37 deaths (18%)
Stay in critical 
care 3 days (1–8)
Hospital stay 
13 days (7–27)
Unplanned
admission to
critical care
356 (14%); 
79 deaths (22%)
Stay in critical 
care 3 days (1–8)
Hospital stay 
15 days (7–28)
No admission to
critical care
1999 (78%); 
84 deaths (4%)
Hospital stay 
4 days (1–8)
Discharged to
ward alive
164 (82%); 
23 (14%) deaths
after discharge 
from critical care
Discharged to
ward alive
277 (78%); 
26 (9%) deaths
after discharge 
from critical care
Figure 3: Adjusted odds ratio for death in hospital after surgery for each country
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case-mix and standards of care in countries with a small 
number of participating hospitals. Although we planned 
to enrol every eligible patient undergoing surgery during 
the study period, we cannot be sure of the exact 
proportion of eligible patients included. Nonetheless, 
assuming the volume of surgery during the cohort week 
is typical of the participating hospitals, these centres 
undertake more than 2·3 million inpatient surgical 
procedures each year, which is 1% of the estimated 
volume of surgery taking place worldwide.1 Whether 
truly repre sentative or not, our ﬁ ndings clearly describe a 
large cross-section of health care in Europe.
Some of our ﬁ ndings might be indicative of limitations 
of commonly used risk-adjustment variables with un-
expected patterns of survival across categories for both 
ASA score and grade of surgery. This ﬁ nding could result 
from the poor ability of clinicians to discriminate between 
the less severe categories of these variables. Random 
partitioning of the countries into three equal groups and 
repetition of the modelling exercise showed much the 
same results with regards to the OR of the relevant eﬀ ect 
factors, showing some stability of the risk adjustment in 
subsets of countries. This stability was further conﬁ rmed 
in more complex models that included interactions 
between variables for which none of the interactions with 
the country factor contributed signiﬁ  cantly to prediction. 
We identiﬁ ed other interactions that did signiﬁ cantly 
contribute to prediction but we did not record a substantial 
change in country eﬀ ects when estimated from the 
extended model including these interactions. We 
therefore decided to use the simpler of the hierarchical 
models for the ﬁ nal analysis because our aim had been to 
construct a parsimonious model that practising clinicians 
would easily understand.
As far as we are aware, this was the ﬁ rst large, 
prospective, international assessment of surgical out-
comes (panel). In some countries, data are available that 
describe survival after speciﬁ c procedures such as 
vascular, joint replacement, or bowel cancer surgery.24–26 
However, these audits are poorly representative of overall 
national surgical populations because high-risk patients 
are under-represented. The few previous estimates 
suggest an overall mortality for unselected inpatient 
surgery of between 1% and 2%,2,3,6,13–16 but these values 
are representative of only a few health-care systems. In a 
previous study13 of national registry data from the 
Netherlands, 30 day mortality was reported as 1·85%, 
which is much the same as the crude hospital mortality 
of 2% for this country in the EuSOS study. In the UK, a 
prospective investigation2 with a very similar methods to 
EuSOS identiﬁ ed a postoperative critical care admission 
rate of 6·7%, which is much the same as to the value of 
6% for EuSOS in the UK.2 However, 30 day mortality 
was 1·6% compared with 3·6% for 60 day in-hospital 
mortality for UK patients in EuSOS. Reports from 
nations outside Europe describe 30 day mortality rates 
from 1·3% to 2·0%.6,14,15
Previous investigators have described the diﬀ erences 
in provision of health services across Europe, in 
particular numbers of critical care beds.10,11 The reported 
seven-times greater provision of critical care beds for 
Germany than for the UK is likely to aﬀ ect rates of 
admission to critical care and postoperative out-
comes.10,11,27 This ﬁ nding is in keeping with our present 
data that show a greater rate of admission to critical care 
after surgery in Germany than in the UK. Other studies 
have shown that fewer than a third of high-risk non-
cardiac surgical patients are admitted to critical care 
after surgery in the UK despite high mortality rates,2–4 
which is consistent with the results of our study; across 
Europe 73% of surgical patients who died were never 
admitted to critical care. This situation contrasts with 
perioperative care for cardiac surgical patients who by 
deﬁ nition have severe comorbid disease and undergo 
major body cavity surgery followed by routine admission 
to critical care with mortality rates of less than 2%.28 
Several reasons could explain why outcomes for cardiac 
and non-cardiac surgical patients diﬀ er but the quality of 
perioperative care is likely to be among the most 
important. The heath-care community increasingly 
recognises the importance of the entire perioperative 
care pathway including pre operative assessment, 
optimisation of coexisting medical disease, integrated 
care pathways relevant to the surgical procedure, WHO 
surgical checklists, advanced haemo dynamic monitoring 
during surgery, early admission to critical care, acute 
pain management and critical-care outreach services, 
and hospital discharge planning together with the 
Panel: Research in context
Systematic review
We searched Medline for original research from the past 10 years describing mortality 
rates in large unselected national and international populations of patients undergoing 
non-cardiac surgery. We used the search terms “surgery”, “mortality”, and “complications” 
and widened our search to include retrospective analyses of health-care registries and 
prospective epidemiological studies. Publications were screened by title and then by 
abstract for relevance to the objectives of our study. Additionally, coinvestigators in 
various European nations searched for publicly available registry analyses reporting 
mortality rates for unselected populations of surgical patients. We identiﬁ ed seven large 
national studies2,3,6,13-16 describing mortality rates for the population of interest, three of 
which involved prospective data collection. No studies were identiﬁ ed that provided 
international comparative data. The last search was done on June 15, 2012.
Interpretation
As far as we are aware, this was the ﬁ rst large prospective international epidemiological 
study of unselected non-cardiac surgical patients and as such it provides a new 
perspective on mortality after surgery. A few national reports describe mortality rates 
from 1·3% to 2·0%.2,3,6,13-16 In our study, the overall crude mortality rate of 4% was higher 
than anticipated. We identiﬁ ed important variations in risk-adjusted mortality rates 
between nations, and critical care resources did not seem to be allocated to patients at 
greatest risk of death. Our ﬁ ndings raise important public health concerns about the 
provision of care for patients undergoing surgery in Europe.
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primary care physician.20,21 Routine audit and reporting 
of data for clinical outcomes has also proved a highly 
eﬀ ective instru ment for improvement of the quality of 
perioperative care.29
Our ﬁ ndings suggest both the need and potential to 
imple ment measures to improve postoperative outcomes. 
In addition to further research in this discipline, the root 
causes of this problem could be better understood through 
increased use of high-quality registries designed to 
capture robust data describing quality of care and clinical 
outcomes for surgical patients. This step would require 
increased funding for this speciﬁ c area of he alth services 
research. The high mortality rate after surgery might be 
modiﬁ ed by changes in the organisation of care.20
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